Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Authors
Keywords
-
Journal
Frontiers in Public Health
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-10
DOI
10.3389/fpubh.2022.967311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru
- (2021) Courtney M. Yuen et al. BMC PUBLIC HEALTH
- Population Pharmacokinetics and Dosage Optimization of Linezolid in Critically Ill Pediatric Patients
- (2021) Mei Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A sensitive and high‐throughput quantitative liquid chromatography high‐resolution mass spectrometry method for therapeutic drug monitoring of 10 β ‐lactam antibiotics, linezolid and two β ‐lactamase inhibitors in human plasma
- (2021) Sarah Van Vooren et al. BIOMEDICAL CHROMATOGRAPHY
- Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method
- (2021) Makoto Kai et al. CLINICAL BIOCHEMISTRY
- Classification Tree Analysis Based On Machine Learning for Predicting Linezolid-Induced Thrombocytopenia
- (2021) Saki Takahashi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
- (2021) Hitoshi Kawasuji et al. BMC Pharmacology & Toxicology
- Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity
- (2021) S. Luque et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients
- (2021) Hitoshi Kawasuji et al. Antibiotics-Basel
- Linezolid resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Iran
- (2021) Azar Dokht Khosravi et al. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
- Effect of renal function on the risk of thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta‐analysis
- (2021) Changcheng Shi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Simultaneous Measurement of 11 Antibiotics for use in the Intensive Care Unit by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry
- (2021) Hanna Woksepp et al. THERAPEUTIC DRUG MONITORING
- Liver function, quantified by the LiMAx test, as a predictor for the clinical outcome of critically ill patients treated with linezolid
- (2021) Rawan Alraish et al. TECHNOLOGY AND HEALTH CARE
- UPLC-MS/MS Determination of Linezolid and Heme in Plasma of Infected Patients and Correlation Analysis
- (2021) Yingying Wang et al. Biomed Research International
- Trend in Antimicrobial Resistance of Staphylococcus aureus: Results from the China Antimicrobial Surveillance Network (CHINET) in the Last 15-Year-Period Reports (2005–2019)
- (2021) Yingjian Liang et al. Infection and Drug Resistance
- Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
- (2020) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of minimum bactericidal concentration, in single or combination drugs, against Mycobacterium tuberculosis
- (2020) Nathally C de S Santos et al. Future Microbiology
- Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
- (2020) Francesca Conradie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation
- (2020) Amaia Soraluce et al. Pharmaceutics
- Pharmacokinetics of linezolid for methicillin-resistant Staphylococcus aureus pneumonia in an adult receiving extracorporeal membrane oxygenation
- (2020) Peter Nikolos et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Distribution of linezolid in tuberculosis lesions in patients with spinal multidrug-resistant tuberculosis
- (2020) Yuan Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Accumulation of Major Linezolid Metabolites in Patients with Renal Impairment
- (2020) Ernane Souza et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics and Dosage Optimization of Linezolid in Patients with Liver Dysfunction
- (2020) Su-hua Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
- (2020) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study
- (2020) Philipp Simon et al. Journal of Clinical Medicine
- Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?—Experience from a prospective observational study
- (2020) Jie Fang et al. Annals of Translational Medicine
- Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimens Simulation and Target Attainment Analysis
- (2020) Wael A. Alghamdi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients
- (2020) Sebastiano Barco et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Augmented Renal Clearance and How to Augment Antibiotic Dosing
- (2020) Iris H. Chen et al. Antibiotics-Basel
- Prolonged infusion of linezolid is associated with improved pharmacokinetic/pharmacodynamic (PK/PD) profiles in patients with external ventricular drains
- (2020) Wenjun Zhao et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue Infections
- (2020) Alison L. Blackman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
- (2020) Fuad Mirzayev et al. EUROPEAN RESPIRATORY JOURNAL
- Bone penetration of linezolid in osteoarticular tuberculosis patients of China
- (2020) Shu’an Wen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Population pharmacokinetics and dosing optimization of linezolid in pediatric patients
- (2019) Si-Chan Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Reappraisal of Linezolid Dosing in Renal Impairment to Improve Safety
- (2019) Ryan L. Crass et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A critical review of HPLC-based analytical methods for quantification of Linezolid
- (2019) Guilherme Felipe dos Santos Fernandes et al. CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
- Ultrahigh-throughput absolute quantitative analysis of linezolid in human plasma by direct analysis in real time mass spectrometry without chromatographic separation and its application to a pharmacokinetic study
- (2019) Lei Yin et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Linezolid dosing in patients with liver cirrhosis
- (2019) S Luque et al. THERAPEUTIC DRUG MONITORING
- Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study
- (2019) Pier Giorgio Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis
- (2019) Yuan Li et al. PLoS One
- Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice
- (2019) Gauri G Rao et al. THERAPEUTIC DRUG MONITORING
- Voltammetric monitoring of linezolid, meropenem and theophylline in plasma
- (2018) Ali K. Attia et al. ANALYTICAL BIOCHEMISTRY
- Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy
- (2018) Takeshi Ide et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Early linezolid-associated lactic acidosis in a patient with Child's class C liver cirrhosis and end stage renal disease
- (2018) Chih-Ning Cheng et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC–MS/MS method
- (2018) M. Paal et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation
- (2018) Xiaofei Wu et al. Drug Design Development and Therapy
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Dose Optimization of Moxifloxacin and Linezolid Against Tuberculosis Using Mathematical Modeling and Simulation
- (2018) M. Tobias Heinrichs et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia
- (2018) Feifan Xie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot study
- (2017) Sebastian G. Wicha et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of the Arktm Immunoassay With Hplc-Uv for Therapeutic Drug Monitoring of Linezolid
- (2017) Simone Castoldi et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetics of linezolid in critically ill patients
- (2016) Predrag Sazdanovic et al. Expert Opinion on Drug Metabolism & Toxicology
- Risk factors associated with high linezolid trough plasma concentrations
- (2016) L. Morata et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis
- (2016) Akosua Adom Agyeman et al. Annals of Clinical Microbiology and Antimicrobials
- Linezolid Induced Adverse Drug Reactions - An Update
- (2015) Kamal Kishor et al. CURRENT DRUG METABOLISM
- Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study: TABLE 1
- (2015) Mathieu S. Bolhuis et al. EUROPEAN RESPIRATORY JOURNAL
- Incidence and risk factors of linezolid-induced lactic acidosis
- (2015) Jae Hyoung Im et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration
- (2015) C. Roger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics
- (2015) Athena L. V. Hobbs et al. PHARMACOTHERAPY
- Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight
- (2014) Takashi Niwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients
- (2014) H.-Y. Dong et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
- (2014) S. Tang et al. EUROPEAN RESPIRATORY JOURNAL
- Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections
- (2014) S. Luque et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation
- (2014) P. Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients
- (2013) Mathieu S. Bolhuis et al. EUROPEAN RESPIRATORY JOURNAL
- Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study
- (2013) Yun Cai et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Clinical implications of antibiotic pharmacokinetic principles in the critically ill
- (2013) Andrew A. Udy et al. INTENSIVE CARE MEDICINE
- Pharmacokinetics of linezolid during extracorporeal membrane oxygenation
- (2013) Francesco G. De Rosa et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
- (2013) Dario Cattaneo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Linezolid for the treatment of drug-resistant tuberculosis in children: A review and recommendations
- (2013) Anthony J. Garcia-Prats et al. TUBERCULOSIS
- Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis
- (2012) D. H. Vu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
- (2012) F. Pea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese Patients
- (2011) Tomohiro Sasaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
- (2010) F. Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients
- (2010) Jan-Willem C. Alffenaar et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and Distribution of Linezolid in Cerebrospinal Fluid in Children and Adolescents
- (2010) Ram Yogev et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis
- (2009) B. McGee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Augmented Renal Clearance
- (2009) Andrew A. Udy et al. CLINICAL PHARMACOKINETICS
- Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy
- (2009) Takashi Niwa et al. CLINICAL THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started